Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar 19;59(5):e173-e174.
doi: 10.1515/cclm-2021-0275. Print 2021 Apr 27.

Letter in reply to the letter to the editor of Harte JV and Mykytiv V with the title "A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data"

Remy J H Martens  1 , Math P G Leers  1
Affiliations
Free article
Comment

Letter in reply to the letter to the editor of Harte JV and Mykytiv V with the title "A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data"

Remy J H Martens et al. Clin Chem Lab Med. .
Free article
No abstract available

Keywords: COVID-19; SARS-CoV-2; cell population data; hemocytometry.

PubMed Disclaimer

Comment on

References

    1. Harte, JV, Mykytic, V. A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil data. Clin Chem Lab Med 2021;59:e169–172.
    1. Martens, RJH, van Adrichem, AJ, Mattheij, NJA, Brouwer, CG, van Twist, DJL, Broerse, J, et al.. Hemocytometric characteristics of COVID-19 patients with and without cytokine Storm syndrome on the Sysmex XN-10 hematology analyzer. Clin Chem Lab Med 2020;59:783–93.
    1. Selvin, E, Juraschek, SP. Diabetes epidemiology in the COVID-19 pandemic. Diabetes Care 2020;43:1690–4. https://doi.org/10.2337/dc20-1295.
    1. Wilk, AJ, Rustagi, A, Zhao, NQ, Roque, J, Martinez-Colon, GJ, McKechnie, JL, et al.. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med 2020;26:1070–6. https://doi.org/10.1038/s41591-020-0944-y.
    1. Chevrier, S, Zurbuchen, Y, Cervia, C, Adamo, S, Raeber, ME, de Souza, N, et al.. A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Rep Med 2021;2:100166. https://doi.org/10.1016/j.xcrm.2020.100166.

LinkOut - more resources